Beauty Health (NASDAQ:SKIN – Get Free Report) and PACS Group (NYSE:PACS – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.
Analyst Ratings
This is a summary of recent recommendations for Beauty Health and PACS Group, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Beauty Health | 1 | 6 | 1 | 0 | 2.00 |
| PACS Group | 0 | 1 | 4 | 1 | 3.00 |
Beauty Health currently has a consensus target price of $2.32, suggesting a potential upside of 148.74%. PACS Group has a consensus target price of $44.40, suggesting a potential upside of 31.38%. Given Beauty Health’s higher probable upside, equities analysts clearly believe Beauty Health is more favorable than PACS Group.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Beauty Health | -3.16% | -15.40% | -1.74% |
| PACS Group | 3.62% | 22.55% | 3.45% |
Earnings and Valuation
This table compares Beauty Health and PACS Group”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Beauty Health | $300.80 million | 0.40 | -$9.52 million | ($0.20) | -4.66 |
| PACS Group | $5.29 billion | 1.00 | $191.54 million | $1.23 | 27.48 |
PACS Group has higher revenue and earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
93.3% of Beauty Health shares are held by institutional investors. 40.3% of Beauty Health shares are held by insiders. Comparatively, 70.4% of PACS Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Risk and Volatility
Beauty Health has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, PACS Group has a beta of -0.03, indicating that its share price is 103% less volatile than the S&P 500.
Summary
PACS Group beats Beauty Health on 12 of the 15 factors compared between the two stocks.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
About PACS Group
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.
